BRPI0615717A2 - inibição da expressão do gene viral usando pequeno rna interferente - Google Patents
inibição da expressão do gene viral usando pequeno rna interferente Download PDFInfo
- Publication number
- BRPI0615717A2 BRPI0615717A2 BRPI0615717-3A BRPI0615717A BRPI0615717A2 BR PI0615717 A2 BRPI0615717 A2 BR PI0615717A2 BR PI0615717 A BRPI0615717 A BR PI0615717A BR PI0615717 A2 BRPI0615717 A2 BR PI0615717A2
- Authority
- BR
- Brazil
- Prior art keywords
- seq
- sequence
- rna
- shrna
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
- C12N15/1131—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing against viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7088—Compounds having three or more nucleosides or nucleotides
- A61K31/713—Double-stranded nucleic acids or oligonucleotides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/11—Antisense
- C12N2310/111—Antisense spanning the whole gene, or a large part of it
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/10—Type of nucleic acid
- C12N2310/14—Type of nucleic acid interfering N.A.
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/36011—Togaviridae
- C12N2770/36111—Alphavirus, e.g. Sindbis virus, VEE, EEE, WEE, Semliki
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Virology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Communicable Diseases (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Physics & Mathematics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2005/032768 WO2006031901A2 (en) | 2004-09-10 | 2005-09-12 | SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF |
USPCT/US2005/032768 | 2005-09-12 | ||
PCT/US2006/021253 WO2007032794A2 (en) | 2005-09-12 | 2006-06-01 | Inhibition of viral gene expression using small interfering rna |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0615717A2 true BRPI0615717A2 (pt) | 2011-05-24 |
Family
ID=37708176
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0615717-3A BRPI0615717A2 (pt) | 2005-09-12 | 2006-06-01 | inibição da expressão do gene viral usando pequeno rna interferente |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1979480A2 (zh) |
JP (1) | JP2009521207A (zh) |
KR (1) | KR20090003147A (zh) |
CN (2) | CN102827841A (zh) |
AU (1) | AU2006291568A1 (zh) |
BR (1) | BRPI0615717A2 (zh) |
CA (1) | CA2622242A1 (zh) |
RU (1) | RU2008114304A (zh) |
WO (1) | WO2007032794A2 (zh) |
Families Citing this family (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009042115A2 (en) * | 2007-09-24 | 2009-04-02 | Rosetta Inpharmatics Llc | Methods of designing short hairpin rnas (shrnas) for gene silencing |
US20100331389A1 (en) * | 2008-09-22 | 2010-12-30 | Bob Dale Brown | Compositions and methods for the specific inhibition of gene expression by dsRNA containing modified nucleotides |
WO2010045384A2 (en) | 2008-10-15 | 2010-04-22 | Somagenics Inc. | Short hairpin rnas for inhibition of gene expression |
CA3151965A1 (en) * | 2008-12-18 | 2010-07-15 | Dicerna Pharmaceuticals, Inc. | Extended dicer substrate agents and methods for the specific inhibition of gene expression |
WO2011008730A2 (en) | 2009-07-13 | 2011-01-20 | Somagenics Inc. | Chemical modification of small hairpin rnas for inhibition of gene expression |
EP3587574B1 (en) * | 2010-08-17 | 2022-03-16 | Sirna Therapeutics, Inc. | Rna interference mediated inhibition of hepatitis b virus (hbv) gene expression using short interfering nucleic acid (sina) |
JOP20200092A1 (ar) | 2014-11-10 | 2017-06-16 | Alnylam Pharmaceuticals Inc | تركيبات iRNA لفيروس الكبد B (HBV) وطرق لاستخدامها |
KR101668954B1 (ko) | 2015-05-29 | 2016-10-24 | 연세대학교 산학협력단 | HCV IRES를 표적으로 하는 C형 간염 바이러스 치료제 siRNA |
WO2018112124A1 (en) * | 2016-12-15 | 2018-06-21 | Meharry Medical College | Antiviral agents |
US11324820B2 (en) | 2017-04-18 | 2022-05-10 | Alnylam Pharmaceuticals, Inc. | Methods for the treatment of subjects having a hepatitis b virus (HBV) infection |
TW202023574A (zh) | 2018-08-13 | 2020-07-01 | 美商阿尼拉製藥公司 | B型肝炎病毒(HBV)dsRNA劑組合物及其使用方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2003070750A2 (en) * | 2002-02-20 | 2003-08-28 | Sirna Therapeutics, Inc | Rna interference mediated inhibition of hepatitis c virus |
WO2006031901A2 (en) * | 2004-09-10 | 2006-03-23 | Somagenics, Inc. | SMALL INTERFERING RNAs THAT EFFICIENTLY INHIBIT VIRAL GENE EXPRESSION AND METHODS OF USE THEREOF |
CN100344331C (zh) * | 2004-09-22 | 2007-10-24 | 广州拓谱基因技术有限公司 | 用于预防或治疗丙型肝炎的靶向小干扰rna制剂及其制备方法 |
-
2006
- 2006-06-01 WO PCT/US2006/021253 patent/WO2007032794A2/en active Application Filing
- 2006-06-01 CN CN2012102773452A patent/CN102827841A/zh active Pending
- 2006-06-01 CA CA002622242A patent/CA2622242A1/en not_active Abandoned
- 2006-06-01 AU AU2006291568A patent/AU2006291568A1/en not_active Abandoned
- 2006-06-01 CN CN2006800418459A patent/CN101305095B/zh not_active Expired - Fee Related
- 2006-06-01 EP EP06784525A patent/EP1979480A2/en not_active Withdrawn
- 2006-06-01 JP JP2008529981A patent/JP2009521207A/ja active Pending
- 2006-06-01 KR KR1020087008905A patent/KR20090003147A/ko not_active Application Discontinuation
- 2006-06-01 BR BRPI0615717-3A patent/BRPI0615717A2/pt not_active Application Discontinuation
- 2006-06-01 RU RU2008114304/13A patent/RU2008114304A/ru unknown
Also Published As
Publication number | Publication date |
---|---|
CN101305095B (zh) | 2012-09-26 |
WO2007032794A3 (en) | 2007-08-30 |
AU2006291568A1 (en) | 2007-03-22 |
WO2007032794A2 (en) | 2007-03-22 |
JP2009521207A (ja) | 2009-06-04 |
RU2008114304A (ru) | 2009-11-20 |
KR20090003147A (ko) | 2009-01-09 |
CN102827841A (zh) | 2012-12-19 |
CN101305095A (zh) | 2008-11-12 |
EP1979480A2 (en) | 2008-10-15 |
CA2622242A1 (en) | 2007-03-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8426380B2 (en) | Inhibition of viral gene expression using small interfering RNA | |
BRPI0615717A2 (pt) | inibição da expressão do gene viral usando pequeno rna interferente | |
Dash et al. | Transfection of HepG2 cells with infectious hepatitis C virus genome. | |
Kanda et al. | Small Interfering RNA Targeted to Hepatitis C Virus 5′ NontranslatedRegion Exerts Potent Antiviral Effect | |
US10982212B2 (en) | Conserved HBV and HCV sequences useful for gene silencing | |
JP2000506010A (ja) | C型肝炎ウイルスリボザイム | |
JPH10510815A (ja) | 肝臓の持続的な再生およびc型肝炎の処置のための組換えベクター | |
Vlassov et al. | shRNAs targeting hepatitis C: effects of sequence and structural features, and comparision with siRNA | |
Das et al. | A small yeast RNA blocks hepatitis C virus internal ribosome entry site (HCV IRES)-mediated translation and inhibits replication of a chimeric poliovirus under translational control of the HCV IRES element | |
Jarczak et al. | Hairpin ribozymes in combination with siRNAs against highly conserved hepatitis C virus sequence inhibit RNA replication and protein translation from hepatitis C virus subgenomic replicons | |
Kim et al. | Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model | |
Sakamoto et al. | Inhibition of hepatitis C virus infection and expression in vitro and in vivo by recombinant adenovirus expressing short hairpin RNA | |
KR100733186B1 (ko) | Hcv 유전자에 특이적인 작은 간섭 rna 및 그를유효성분으로 포함하는 c형 간염 치료제 | |
Wilson et al. | Future promise of siRNA and other nucleic acid based therapeutics for the treatment of chronic HCV | |
Nawtaisong et al. | Trans-splicing group I intron targeting hepatitis C virus IRES mediates cell death upon viral infection in Huh7. 5 cells | |
MX2008003504A (en) | Inhibition of viral gene expression using small interfering rna | |
Shier et al. | Effect of RNA interference on the hepatitis C virus core expression in HepG2/C3A cells using genotype 4 isolates from Saudi patients | |
KR100490699B1 (ko) | 씨형 간염 바이러스의 아이알이에스 발현 세포에서만 선택적으로 유전자 활성을 유도하는 트랜스-스플라이싱 리보자임 | |
KR101534462B1 (ko) | 사이클린 a2 저해제를 포함하는 c형간염 예방 및 치료용 조성물 | |
Gromeier et al. | The Polypyrimidine Tract Binding Protein Is | |
Frese et al. | Inhibition of Hepatitis C virus by nucleic acid-based antiviral approaches |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B11A | Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing | ||
B11Y | Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette] |